BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34307388)

  • 1. C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
    Dong X; Liu Y; Deng X; Shao J; Tian S; Chen S; Huang R; Lin Z; Chen C; Shen L
    Front Cell Dev Biol; 2021; 9():707970. PubMed ID: 34307388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
    Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 induces the carcinogenesis of thyroid cancer through regulation by miR-141-3p and GLUT1.
    Huang L; Li Z; Xu Z; Yu R; Ding C; Sun T; Kong L; Xia Z
    Heliyon; 2024 Jun; 10(11):e31778. PubMed ID: 38845937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression.
    Watanabe K; Tasaka K; Ogata H; Kato S; Ueno H; Umeda K; Isobe T; Kubota Y; Sekiguchi M; Kimura S; Sato-Otsubo A; Hiwatari M; Ushiku T; Kato M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Gene Ther; 2024 Apr; ():. PubMed ID: 38622340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in
    Guo M; Liu J; Zhang Y; Gu J; Xin J; Du M; Chu H; Wang M; Liu H; Zhang Z
    J Biomed Res; 2024 Jan; ():1-10. PubMed ID: 38807485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.
    Tian H; Yu JL; Chu X; Guan Q; Liu J; Liu Y
    Front Oncol; 2024; 14():1389713. PubMed ID: 38699634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer.
    Tan B; Zhang J; Wang W; Ma H; Yang Y
    Apoptosis; 2023 Apr; 28(3-4):397-413. PubMed ID: 36436119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability.
    Mao C; Li X
    Environ Toxicol; 2022 May; 37(5):1104-1112. PubMed ID: 35044041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker.
    Zou K; Gao P; Xu X; Zhang W; Zeng Z
    Comput Math Methods Med; 2023; 2023():2912968. PubMed ID: 36703939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC.
    Hu DM; Zhang WD; Shi ZE; Zhang MY; Li R; Wang QX; Ji XL; Qu YQ
    Front Genet; 2022; 13():937069. PubMed ID: 36160018
    [No Abstract]   [Full Text] [Related]  

  • 11. The Potential Mechanism of HDAC1-Catalyzed Histone Crotonylation of Caspase-1 in Nonsmall Cell Lung Cancer.
    Jiang C; Liao J; Yang F; Jiang T; Zhang D; Xin Y
    Evid Based Complement Alternat Med; 2022; 2022():5049116. PubMed ID: 35958929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination.
    Rong G; Pan Z; Ding M; Wang L
    Environ Toxicol; 2022 Mar; 37(3):603-611. PubMed ID: 34873829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PESV represses non-small cell lung cancer cell malignancy through circ_0016760 under hypoxia.
    Zhang H; Zhang H; Zhu J; Liu H; Zhou Q
    Cancer Cell Int; 2021 Nov; 21(1):628. PubMed ID: 34838012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally Diverse Diterpenes from the South China Sea Soft Coral
    Song YT; Yu DD; Su MZ; Luo H; Cao JG; Liang LF; Yang F; Guo YW
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer.
    Luo Y; Hu S; Wang F; Yang J; Gong D; Xu W; Xu X; Min L
    Transl Cancer Res; 2022 Oct; 11(10):3803-3813. PubMed ID: 36388045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 17. IMP4 Silencing Inhibits the Malignancy of Lung Adenocarcinoma via ERK Pathway.
    Li R; Han Z; Ma W; Zhang L; Zhang X; Jiang Y; Dong W
    J Oncol; 2022; 2022():8545441. PubMed ID: 36317123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
    Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
    Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
    Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
    Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.